# Biohaven (BHVN) — Earnings

BHVN · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/bhvn/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q3 2025 |
| Period end | Sep 30, 2025 |
| EPS actual | −$1.64 |
| EPS estimate | −$1.90 |
| EPS surprise | +13.73% |
| Revenue surprise | −100.00% |
| Revenue | $0.00 |
| Revenue estimate | $375,091.00 |
| Reported | Nov 10, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1935979/000193597925000092/bhvn-20250930.htm) |

Biohaven's most recent results in the table are for Q3 2025, reported on November 10, 2025. It posted a loss of $1.64 per share, narrower than the $1.90 loss expected, a 13.73% beat. No revenue was reported, against an estimate of about $375,000. Compared with Q3 2024, the loss narrowed slightly from $1.70 per share.

Every quarter in the table, from Q3 2022 on, is a loss. The annual loss per share grew from $5.66 in 2023 to $9.39 in 2024. The first three quarters of 2025 add up to a loss of $5.75, against $7.54 for the same period of 2024. The largest quarterly loss in the table is Q2 2024, at $3.64 per share, and the narrowest is Q1 2023, at $1.03. No revenue appears in any quarter. Biohaven beat the EPS estimate in 4 of 13 quarters. The largest misses were Q4 2022 and Q2 2024.

Biohaven reported Q4 results on March 23, 2023, February 29, 2024 and March 3, 2025. The table has no report after Q3 2025, so later quarters are not yet reflected here. They will show whether the loss per share stays below the 2024 level.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q3 2025 | Nov 10, 2025 | −$1.90 | −$1.64 | 13.73% | $375,091.00 | — |
| Q2 2025 | Aug 11, 2025 | −$1.90 | −$1.94 | -1.99% | — | — |
| Q1 2025 | May 12, 2025 | −$1.70 | −$2.17 | -27.62% | — | — |
| Q4 2024 | Mar 3, 2025 | −$1.57 | −$1.85 | -17.47% | — | — |
| Q3 2024 | Nov 12, 2024 | −$1.70 | −$1.70 | 0.09% | — | — |
| Q2 2024 | Aug 9, 2024 | −$1.78 | −$3.64 | -104.41% | — | — |
| Q1 2024 | May 9, 2024 | −$1.55 | −$2.20 | -42.07% | — | — |
| Q4 2023 | Feb 29, 2024 | −$1.41 | −$1.81 | -28.25% | — | — |
| Q3 2023 | Nov 14, 2023 | −$1.33 | −$1.50 | -13.11% | — | — |
| Q2 2023 | Jul 31, 2023 | −$1.18 | −$1.32 | -11.69% | — | — |
| Q1 2023 | May 12, 2023 | −$1.41 | −$1.03 | 26.92% | — | — |
| Q4 2022 | Mar 23, 2023 | −$1.22 | −$3.32 | -172.31% | — | — |
| Q3 2022 | Nov 9, 2022 | −$2.42 | −$1.75 | 27.54% | — | — |

## Frequently Asked Questions

### When did Biohaven (BHVN) last report earnings?

Biohaven last reported on Nov 10, 2025, covering fiscal Q3 2025.

### Did BHVN beat earnings estimates?

Yes. Biohaven reported EPS of −$1.64 for Q3 2025 against a −$1.90 estimate — a 13.73% beat.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).